Pressure BioSciences Restructures as Equity, Credit Market-Freeze Continues | GenomeWeb
The global financial crisis has hit home for at least one proteomics firm.
Pressure BioSciences, with enough cash to last until the middle of 2009, this week announced that it will lay off eight staffers and cut back its research and development programs as global credit and equity markets remain frozen.
The firm said that the cost-cutting will allow it to focus on the parts of its business that have the greatest likelihood for success, including mass spectrometry.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nature this week: modern European bison analysis, phased diploid genome assembly algorithms, and more.

Actress Jennifer Lopez is working with NBC on a CRISPR-inspired television show, according to the Hollywood Reporter.

Researchers trace the origin of one human papillomavirus lineage to Neanderthals or Denisovans, Vox reports.

The BabySeq project faces lower-than-expected enrollment rates, according to ScienceInsider.